Genmab A (GMAB) EPS (Basic) (2018 - 2026)
Genmab A (GMAB) posted EPS (Basic) of $87.79 for Q1 2026, up 0.96% on a QoQ basis from $86.95 in Q3 2025, and up 9.64% year-over-year from $80.07 in Q1 2025.
Genmab A (GMAB) EPS (Basic) (2018 - 2026) Analysis & Trends
Genmab A's EPS (Basic) history runs 6 years deep, the most recent figure standing at $87.79 for Q1 2026.
- Quarterly EPS (Basic) rose 9.64% year-over-year to $87.79 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186.96 (up 3.29% YoY) and the FY2025 annual result came in at $14.88, down 80.84% from the prior year.
- EPS (Basic) was $87.79 for Q1 2026 at Genmab A, up from $86.95 in the prior quarter.
- Across five years, EPS (Basic) topped out at $87.79 in Q1 2026 and bottomed at $8.42 in Q2 2024.
- A 3-year average of $54.67 and a median of $71.99 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2025 — EPS (Basic) climbed 19.78% — and 2026, when it advanced 9.64%.
- Genmab A's EPS (Basic) stood at $20.05 in 2024, then surged by 333.71% to $86.95 in 2025, then increased by 0.96% to $87.79 in 2026.
- Business Quant data shows GMAB's EPS (Basic) at $87.79 in Q1 2026, $86.95 in Q3 2025, and $10.08 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Genmab A | 1.87 Bn | 350.00 Mn | 831.00 Mn | 87.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.79 |
| Sep 30, 2025 | 86.95 |
| Jun 30, 2025 | 10.08 |
| Mar 31, 2025 | 80.07 |
| Dec 31, 2024 | 20.05 |
| Sep 30, 2024 | 72.60 |
| Jun 30, 2024 | 8.42 |
| Mar 31, 2024 | 71.38 |
| Sep 30, 2020 | 0.00 |
| Dec 31, 2019 | 0.00 |
| Sep 30, 2019 | 11.39 |
| Dec 31, 2018 | 0.00 |